DaysLeft: Life Countdown
Life Expectancy & Countdown
About
Visualize your estimated remaining days and explore future lifestyle scenarios. Track habits, discover factors influencing longevity, and generate shareable life projection cards. Small changes today can create thousands of additional days tomorrow.
What's New in DaysLeft
1.1.7
July 14, 2026
Refreshed App Store visuals, UI polish, performance improvements, and bug fixes for a smoother DaysLeft experience.
In-App Purchases
$14.99
Lifetime Access
Unlock all premium features permanently.
FAQ
What is the main purpose of DaysLeft?
DaysLeft helps you visualize your estimated remaining days and explore future lifestyle scenarios. It aims to motivate you by showing how small changes today can impact your longevity.
Does DaysLeft provide medical advice?
No, DaysLeft is an educational lifestyle estimation tool and is not a medical device. It does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for medical decisions.
What kind of insights does DaysLeft offer?
DaysLeft offers insights into lifestyle factors that may influence longevity and advanced AI-powered insights. It transforms lifestyle information into a motivating timeline.
Can I share my life projections from DaysLeft?
Yes, DaysLeft allows you to generate shareable life projection cards. This feature helps you communicate your life scenarios and goals.
What devices does DaysLeft support?
DaysLeft is currently supported on iPhone and iPod devices. It is designed for iOS users.
How often is DaysLeft updated?
The latest version of DaysLeft is 1.1.5, which was last updated on June 18, 2026. Updates typically occur to improve features and address any issues.
What is the age rating for DaysLeft?
DaysLeft has an age rating of 17+. This indicates that some content or features may be considered mature for younger users.
Does DaysLeft have ads?
No, DaysLeft does not contain advertisements. The app is free to download and use, with optional in-app purchases available.